P&G nabs Nioxin
This article was originally published in The Rose Sheet
Executive Summary
With purchase of Nioxin Research Laboratories, announced Sept. 3, P&G gains range of innovative professional hair-care products that focus on the scalp to improve appearance of thinning hair, firm says. Nioxin offerings currently are distributed through salons and salon stores in more than 40 countries, P&G says. Acquisition is in harmony with P&G's strategy of focusing on "faster growing, higher margin and more asset-efficient businesses," according to release. The personal care giant will keep Nioxin's brand portfolio, organization and distribution network in place in order to strengthen its commitment to growth in professional salon channel; Brian Graham will stay on as CEO of Nioxin, P&G notes. "This acquisition is a great strategic fit given P&G's leadership and proven strength in its retail scalp care business. Further, P&G's global scale creates opportunities to further grow the Nioxin brand in key markets around the world," says Robert Jongstra, president, P&G Professional Care
You may also be interested in...
Pro Hair-Care Firm Nioxin Looks To Expand Global Reach As P&G Subsidiary
Procter & Gamble's acquisition of Nioxin positions the professional hair-care company to expand its reach globally and potentially become a "billion dollar brand," according to Nioxin CEO Brian Graham
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.